Cost of patients with hemophilia A treated with standard half-life or extended half-life FVIII in Spain.

CONCLUSIONS: According to this model, use of SHL rFVIII versus EHL rFVIII products could lead to savings for the Spanish National Health System.
PMID: 32597317 [PubMed - as supplied by publisher]

Source: Expert Review of Pharmacoeconomics and Outcomes Research - July 1, 2020 Category: Health Management Tags: Expert Rev Pharmacoecon Outcomes Res Source Type: research